MetCure Therapeutics is an Italian-based company founded in 2013 operating in the fields of Biopharma, Biotechnology, and Life Sciences. The company, known for its expertise in Gnatologia, Implantoprotesi, and Conservativa, operates under the leadership of Studio Dentistico Dott. Carlo Zampollo.
The most recent investment in MetCure Therapeutics was a grant investment on 01 May 2015, with the Georgia Research Alliance Venture Fund being the participating investors.
Given the focus on innovative dental solutions in the biopharma and biotechnology sectors, the company's unique approach and dedicated leadership position it as a promising prospect within the life sciences industry.
No recent news or press coverage available for MetCure Therapeutics.